What's new?

The nominations follow a successful seed funding led by Sofinnova Partners   PinCell, a biotechnology company developing novel therapies for rare dermatological diseases, announced today the appointment of Gabriella Camboni, M.D., as Chief Executive Officer of PinCell and Member of the Board of Directors, and Luigi...

BioFun-1 provides growers with a novel mode of action to address increasing fungicide resistance   Environmentally friendly, innovative biofungicide with potential for pre- and post-harvest applications   GHENT, Belgium, May 06, 2020 (GLOBE NEWSWIRE) -- Biotalys NV, a transformative food and crop protection company...

Analysis supports ensifentrine’s efficacy in COPD as monotherapy and on top of standard of care treatment in patients who remain symptomatic Six abstracts accepted demonstrating ensifentrine’s potential across treatment settings and formulations LONDON, May 01, 2020 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM: VRP) (...

The investment marks a significant step forward making plastic circularity a reality MONTREAL, April 30, 2020 /CNW Telbec/ – Pyrowave, a company that developed a world leading technology allowing infinite recycling of plastics, announced today the closing of a series B investment. This investment marks the first st...

Biotech executive, Julia Berretta, Ph.D., is named Chief Executive Officer  MILAN, Italy – April 29, 2020 —  Genespire, a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, announced today the successful close of a €16M Series A financing fro...

The funds will be used to accelerate the development of EnginZyme’s technology platform and take its first internal production process to pilot April 22, 2020 02:00 AM Eastern Daylight Time STOCKHOLM–(BUSINESS WIRE)–EnginZyme, the cell-free synthetic biology company, today announced a Series A investment of €6.4 mi...

The funds will enable the company to move toward clinical trials for Parkinson’s Disease and expand its platform into multiple disease indications SAN FRANCISCO–(BUSINESS WIRE)– Nitrome Biosciences (Nitrome), a privately-held biopharmaceutical company developing a platform around a newly identified class of enzymes...

This investment brings the total financing by Sofinnova Partners to €25 million over the past six months   MILAN, Italy – April 20, 2020 – Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan, announced today an investment in Genespire, a Milan-based gene-therap...

REHOVOT, Israel, April 20, 2020 — Pi-Cardia Ltd., a global leader in the development of non-implant catheter-based solutions for treating heart valve calcification, announced today it has closed a $27 million round of financing, led by Sofinnova Partners, a leading European life sciences venture capital firm, and j...

SAB will provide scientific and technical advice to accelerate the development of Biotalys’ unique biocontrol solutions   GHENT, Belgium, April 20, 2020 (GLOBE NEWSWIRE) — Biotalys NV, a rapidly growing and transformative Food and Crop protection company developing a new generation of protein-based biocontrols, tod...